132 related articles for article (PubMed ID: 8047165)
1. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice.
Grainger DJ; Kemp PR; Liu AC; Lawn RM; Metcalfe JC
Nature; 1994 Aug; 370(6489):460-2. PubMed ID: 8047165
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a), plasmin modulation, and atherogenesis.
Harpel PC; Hermann A; Zhang X; Ostfeld I; Borth W
Thromb Haemost; 1995 Jul; 74(1):382-6. PubMed ID: 8578490
[TBL] [Abstract][Full Text] [Related]
3. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
[TBL] [Abstract][Full Text] [Related]
5. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
[TBL] [Abstract][Full Text] [Related]
6. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
Li H; Gu S; Cao X; Wang Z; She M
Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways.
Miyata M; Biro S; Kaieda H; Tanaka H
FEBS Lett; 1995 Dec; 377(3):493-6. PubMed ID: 8549783
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta: the key to understanding lipoprotein(a)?
Grainger DJ; Metcalfe JC
Curr Opin Lipidol; 1995 Apr; 6(2):81-5. PubMed ID: 7773572
[TBL] [Abstract][Full Text] [Related]
10. Density-dependent shift of transforming growth factor-beta-1 from inhibition to stimulation of vascular smooth muscle cell growth is based on unconventional regulation of proliferation, apoptosis and contact inhibition.
Hneino M; Bouazza L; Bricca G; Li JY; Langlois D
J Vasc Res; 2009; 46(2):85-97. PubMed ID: 18596377
[TBL] [Abstract][Full Text] [Related]
11. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
[TBL] [Abstract][Full Text] [Related]
12. [Molecular basis of preventive effect of human apolipoprotein-1 on murine vascular smooth muscle cell proliferation and lipid deposition induced by oxidized low density lipoprotein].
Yu M; Gu SM; Zhou L; Zhao GF; Yu LQ; Zhang H; She MP
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):494-7. PubMed ID: 12887765
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
[TBL] [Abstract][Full Text] [Related]
15. Effects of wild-type (Trp72) and mutant (Arg72) apolipoprotein(a) kringle IV-10 on the proliferation of human arterial smooth muscle cells.
Yu H; Hong J; Wang B; Peng F; Li X; He C
Chin Med J (Engl); 2003 May; 116(5):721-6. PubMed ID: 12875689
[TBL] [Abstract][Full Text] [Related]
16. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis.
Grainger DJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):399-404. PubMed ID: 14699019
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells.
Kojima S; Rifkin DB
J Cell Physiol; 1993 May; 155(2):323-32. PubMed ID: 8482724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
